Impact of GLP-1 receptor agonist-based therapies on cardiovascular and renal outcomes in diabetic and non-diabetic patients with CKD

Impact of GLP-1 receptor agonist-based therapies on cardiovascular and renal outcomes in diabetic and non-diabetic patients with CKD

Abstract Background The effect of glucagon-like peptide-1 (GLP-1) receptor agonists-based therapies on cardiovascular and renal outcomes has not been systematically reviewed across baseline kidney function groups. We conducted a systematic review and meta-analysis of randomized controlled trials (RC...

Full description

Saved in:
Bibliographic Details
Main Authors: Aliona Siniukovich, Christoforos K. Travlos, Sarah Freedman, Thomas A. Mavrakanas, Karim Gariani
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Diabetology & Metabolic Syndrome
Online Access:https://doi.org/10.1186/s13098-025-01831-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items